Skip to main content
Erschienen in: Cancer Causes & Control 5/2012

01.05.2012 | Original paper

Racial and ethnic disparities in survival of US children with acute lymphoblastic leukemia: evidence from the SEER database 1988–2008

verfasst von: William B. Goggins, Fiona F. K. Lo

Erschienen in: Cancer Causes & Control | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Prior studies have shown poorer survival from childhood acute lymphoblastic leukemia (ALL) among some minorities compared to non-Hispanic whites (NHW). Here, we examine whether these survival disparities have persisted and to see whether they also exist for Asian and Hispanic subgroups.

Methods

Using data from the US National Cancer Institute’s Surveillance, Epidemiology and End Results program from 1988 to 2008, we compared all natural-cause survival for children aged 19 years or under diagnosed with ALL using Cox proportional hazards models adjusted for age, diagnosis year, gender and disease immunophenotype.

Results

Black, Hispanic and Native American children continue to have significantly poorer survival than NHW. Unlike previous studies, we found that Asian Americans also had significantly worse survival. Among Asian subgroups, Vietnamese (relative risk [RR] = 2.44, 95 % CI = 1.50–3.97) and Filipinos (RR = 1.64, 95 % CI = (1.13–2.38) had significantly poorer survival, while other East Asian groups, except Chinese, had non-significantly worse survival. Most Hispanic subgroups had RRs around 2.

Conclusion

Previously observed poorer prognosis for childhood ALL for some minority groups appears to be shared by most Asians as well. Further research is needed to find explanations for the poorer survival of minority children with ALL and possible treatment implications.
Literatur
2.
Zurück zum Zitat Smith MA, Seibel NL, Altekruse SF et al (2010) Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol 28:2625–2634PubMedCrossRef Smith MA, Seibel NL, Altekruse SF et al (2010) Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol 28:2625–2634PubMedCrossRef
3.
Zurück zum Zitat Kadan-Lottick NS, Ness KK, Bhatia S et al (2003) Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia. JAMA 290(15):2008–2014PubMedCrossRef Kadan-Lottick NS, Ness KK, Bhatia S et al (2003) Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia. JAMA 290(15):2008–2014PubMedCrossRef
4.
Zurück zum Zitat Bhatia S, Sather HN, Heerema NA et al (2002) Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood 100:1957–1964PubMedCrossRef Bhatia S, Sather HN, Heerema NA et al (2002) Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood 100:1957–1964PubMedCrossRef
5.
Zurück zum Zitat Pollock BH, DeBaun MR, Camitta BM et al (2003) Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Clin Oncol 18:813–823 Pollock BH, DeBaun MR, Camitta BM et al (2003) Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Clin Oncol 18:813–823
7.
Zurück zum Zitat Therneau TM, Grambsch PM, Fleming TR (1990) Martingale-based residuals for survival models. Biometrika 77:147–169CrossRef Therneau TM, Grambsch PM, Fleming TR (1990) Martingale-based residuals for survival models. Biometrika 77:147–169CrossRef
9.
Zurück zum Zitat Goggins WB, Wong G (2009) Cancer among Asian Indians/Pakistanis living in the United States: low incidence and generally above average survival. Cancer Causes Control 20:635–643PubMedCrossRef Goggins WB, Wong G (2009) Cancer among Asian Indians/Pakistanis living in the United States: low incidence and generally above average survival. Cancer Causes Control 20:635–643PubMedCrossRef
10.
Zurück zum Zitat Goggins WB, Wong G (2007) Poor survival for US Pacific Islander cancer patients: evidence from the surveillance, epidemiology and end results database: 1991 to 2004. J Clin Oncol 36:5738–5741CrossRef Goggins WB, Wong G (2007) Poor survival for US Pacific Islander cancer patients: evidence from the surveillance, epidemiology and end results database: 1991 to 2004. J Clin Oncol 36:5738–5741CrossRef
12.
13.
Zurück zum Zitat Johnson KA, Aplenc R, Bagatell R (2011) Survival by race among children with extracranial solid tumors in the United States between 1985 and 2005. Pediatr Blood Cancer 56:425–431PubMedCrossRef Johnson KA, Aplenc R, Bagatell R (2011) Survival by race among children with extracranial solid tumors in the United States between 1985 and 2005. Pediatr Blood Cancer 56:425–431PubMedCrossRef
14.
Zurück zum Zitat Lin SS, Clarke CA, Prehn AW et al (2002) Survival differences among Asian subpopulations in the United States after prostate, colorectal, breast and cervical carcinomas. Cancer 94:1175–1182PubMedCrossRef Lin SS, Clarke CA, Prehn AW et al (2002) Survival differences among Asian subpopulations in the United States after prostate, colorectal, breast and cervical carcinomas. Cancer 94:1175–1182PubMedCrossRef
15.
Zurück zum Zitat Ooi SL, Martinez ME, Li CI (2011) Disparities in breast cancer characteristics and outcomes by race/ethnicity. Breast Cancer Res Treat 127:729–738PubMedCrossRef Ooi SL, Martinez ME, Li CI (2011) Disparities in breast cancer characteristics and outcomes by race/ethnicity. Breast Cancer Res Treat 127:729–738PubMedCrossRef
16.
Zurück zum Zitat Clegg LX, Li FP, Hankey BF et al (2002) Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) program population-based study. Arch Intern Med 162:1985–1993PubMedCrossRef Clegg LX, Li FP, Hankey BF et al (2002) Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) program population-based study. Arch Intern Med 162:1985–1993PubMedCrossRef
17.
Zurück zum Zitat Bhatia S (2004) Influence of race and socioeconomic status on outcome of children treated for childhood acute lymphoblastic leukemia. Curr Opin Pediatr 16:9–14PubMedCrossRef Bhatia S (2004) Influence of race and socioeconomic status on outcome of children treated for childhood acute lymphoblastic leukemia. Curr Opin Pediatr 16:9–14PubMedCrossRef
18.
Zurück zum Zitat Yang JJ, Cheng C, Devidas M et al (2011) Ancestry and pharmacogenetics of relapse in acute lymphoblastic leukemia. Nat Genet 43(3):237–241 Yang JJ, Cheng C, Devidas M et al (2011) Ancestry and pharmacogenetics of relapse in acute lymphoblastic leukemia. Nat Genet 43(3):237–241
19.
Zurück zum Zitat Rubnitz JE, Pui CH (2003) Recent advances in the treatment and understanding of childhood acute lymphoblastic leukaemia. Cancer Treat Rev 29:31–44PubMedCrossRef Rubnitz JE, Pui CH (2003) Recent advances in the treatment and understanding of childhood acute lymphoblastic leukaemia. Cancer Treat Rev 29:31–44PubMedCrossRef
20.
Zurück zum Zitat Collie-Duguid ES, Pritchard SC, Powrie RH et al (1999) The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics 9:37–42PubMedCrossRef Collie-Duguid ES, Pritchard SC, Powrie RH et al (1999) The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics 9:37–42PubMedCrossRef
21.
Zurück zum Zitat Lund MJ, Eliason MT, Haight AE et al (2009) Racial/ethnic diversity in children’s oncology clinical trials. Cancer 115:3808–3816PubMedCrossRef Lund MJ, Eliason MT, Haight AE et al (2009) Racial/ethnic diversity in children’s oncology clinical trials. Cancer 115:3808–3816PubMedCrossRef
22.
Zurück zum Zitat Clegg LX, Reichman ME, Hankey BF et al (2007) Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies. Cancer Causes Control 18:177–187PubMedCrossRef Clegg LX, Reichman ME, Hankey BF et al (2007) Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies. Cancer Causes Control 18:177–187PubMedCrossRef
23.
Zurück zum Zitat Conter V, Bartram CR, Valsecchi MG et al (2010) Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood 115:3206–3214PubMedCrossRef Conter V, Bartram CR, Valsecchi MG et al (2010) Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood 115:3206–3214PubMedCrossRef
Metadaten
Titel
Racial and ethnic disparities in survival of US children with acute lymphoblastic leukemia: evidence from the SEER database 1988–2008
verfasst von
William B. Goggins
Fiona F. K. Lo
Publikationsdatum
01.05.2012
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 5/2012
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-012-9943-8

Weitere Artikel der Ausgabe 5/2012

Cancer Causes & Control 5/2012 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.